ASCO 2014, Melanoma|May 30, 2014 8:20 pm

ASCO preview 2014: TheMelanomaCenter edition


It’s once again time for ASCO, or the American Society of Clinical Oncology, where more than 25,000 oncology doctors as well as countless pharma, biotech, genomic testing, and assorted media types converge on downtown Chicago and the McCormick Convention Center and try and sort out which meetings to attend.

ASCO is truly an assault on your senses; there is so much going on at all times, it is essentially impossible to be at everything. Your best hope is to, upfront, identify the most important things to your practice and place them on your calendar. ASCO makes that quite easy with the AM iPlanner app (App stores) or the online version, which allows you to create a calendar, with Favorites, of things you want to see/hear, and upload those events to your “real” calendar. Luckily for me, I can focus on the Melanoma trackā€¦until a few years ago, when the anti-PD1 antibodies exploded onto the scene with unbelievably good results. Last year, I had to add the “Developmental Therapeutics” (Phase I) track to my calendar, further complicating my time at ASCO. This year, it appears once again that the Developmental Therapeutics sessions will dominate my time, as there are numerous exciting new trials to be presented.

That doesn’t even include the numerous meetings that are essential to our clinical and research program at the Atlantic Melanoma Center, to reinforce relationships with other melanoma specialists and various industry research sponsors.

Having arrived in Chicago earlier today, I am finalizing my schedule before beginning to dive into the meeting this evening (Friday).

For those interested, here are the sessions that I plan to attend:

 

Saturday, May 31:

Emerging Combination Therapies

Melanoma General Poster Session

Frontline Approach to Metastatic BRAF-Mutant Melanoma

From Coley to Cure: Past, Present and Future of Immunotherapy for Melanoma

 

Sunday, June 1:

Novel Combination Therapies for Melanoma

Developmental Therapeutics-Immunotherapy General Poster Session

 

Monday, June 2:

Selected (Discussed) Melanoma Poster Session

Internet, Social Media, Privacy Regulations and Clinical Trials

Oral Abstracts, Melanoma

Selected (Discussed) Developmental Therapeutics-Immunotherapy Poster Session

 

Tuesday, June 3:

Biology of Basal Cell, Squamous Cell, and Merkel Cell Carcinomas

Oral Abstracts, Developmental Therapeutics-Immunotherapy

 

Then return Tuesday evening after more meetings (various meetings are scattered throughout the time here)

I will start to preview some of the trial results in future posts.

Eric Whitman, MD

Senior Editor

TheMelanomaCenter.com

 

 


Tags: ,
  • Share this post:
  • Facebook
  • Twitter
  • Delicious
  • Digg
Shopping Cart (0 Items)
Your cart is empty!


Subtotal: $0.00
Total: $0.00